Anthracycline- And Trastuzumab-Induced Cardiotoxicity: A Retrospective Study

Medical Oncology - United States
doi 10.1007/s12032-016-0797-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Reducing Anthracycline-Induced Cardiotoxicity Through Pharmacogenetics

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2018English

Anthracycline Cardiotoxicity

2012English

Role of Nebivolol in Anthracycline-Induced Cardiotoxicity

International Journal of Research in Medical Sciences
2019English

Cardiac Magnetic Resonance Characteristics of Acute Anthracycline-Induced Cardiotoxicity

Journal of Cardiovascular Magnetic Resonance
Nuclear MedicineRadiologyUltrasound TechnologyCardiologyFamily PracticeRadiologicalCardiovascular MedicineImaging
2016English

Update on Pathophysiology and Preventive Strategies of Anthracycline-Induced Cardiotoxicity

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2018English

Strategies to Prevent Anthracycline-Induced Cardiotoxicity in Cancer Survivors

Cardio-Oncology
2019English

Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study

Oncologist
Cancer ResearchMedicineOncology
2013English

ABCC1polymorphisms in Anthracycline-Induced Cardiotoxicity in Childhood Acute Lymphoblastic Leukaemia

Cell Biology International
MedicineCell Biology
2011English

Managing Anthracycline-Induced Cardiotoxicity: Beginning With the End in Mind

Future Cardiology
Molecular MedicineCardiovascular MedicineCardiology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy